Document:

bicx_ex101.htm

EXHIBIT 10.1
  
 DIRECTOR AGREEMENT
  
 This DIRECTOR AGREEMENT is entered into as of March 1, 2019 (the “Agreement”), by and between BioCorRx Inc., a Nevada corporation (the “Company”), and _________, an individual with an address of ________________________________________ (the “Director”). 
  
 WHEREAS, the Company desires to continue with the services of the Director and Chairman of the Board, and desires to enter into an agreement with the Director with respect to such appointment; and
  
 WHEREAS, the Director is willing to continue to serve the Company on the terms set forth herein and in accordance with the provisions of this Agreement.
  
 NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows: 
  
 1. Position. Subject to the terms and provisions of this Agreement, the Company shall cause the Director to be appointed, and the Director hereby agrees to serve the Company in such position, upon the terms and conditions hereinafter set forth, provided, however, that the Director’s continued service on the Board of Directors of the Company (the “Board”) after the next annual stockholders’ meeting shall be subject to approval by the Company’s stockholders.
  
 2. Duties. 
  
 (a) During the Directorship Term (as defined herein), the Director shall make reasonable business efforts to attend all Board meetings, serve on appropriate subcommittees as reasonably requested by the Board, make himself available to the Company at mutually convenient times and places, attend external meetings and presentations, as appropriate and convenient, and perform such duties, services and responsibilities, and have the authority commensurate to such position.
  
 (b) The Director will use his best efforts to promote the interests of the Company. The Company recognizes that the Director (i) is or may become a full-time executive employee of another entity and that his responsibilities to such entity must have priority and (ii) sits or may sit on the board of directors of other entities. Notwithstanding the same, the Director will use reasonable business efforts to coordinate his respective commitments so as to fulfill his obligations to the Company and, in any event, will fulfill his legal obligations as a Director. Other than as set forth above, the Director will not, without the prior notification to the Board, engage in any other business activity which could materially interfere with the performance of his duties, services and responsibilities hereunder or which is in violation of the reasonable policies established from time to time by the Company, provided that the foregoing shall in no way limit his activities on behalf of (i) any current employer and its affiliates or (ii) the board of directors of any entities on which he currently sits. At such time as the Board receives such notification, the Board may require the resignation of the Director if it determines that such business activity does in fact materially interfere with the performance of the Director’s duties, services and responsibilities hereunder.
  
  	 
	1
	 
 
	 

  
 3. Compensation.
  
 (a) The Director shall receive a quarterly cash stipend of Fifteen Thousand Dollars ($15,000). For so long as the Director serves as the chair of either the Audit Committee of the Board, the Compensation Committee of the Board or the Nominating Committee of the Board the amount of such quarterly cash stipend may be increased from time to time. 
  
 (b) Common Stock. The Director shall be issued, upon the last day of each fiscal quarter, commencing in the quarter in which the Director enters into this Agreement, provided the Director is a member of the Board as of such date, the number of shares of the Company’s common stock equivalent to Five Thousand Dollars ($5,000) as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter.
  
 (c) Independent Contractor. The Director’s status during the Directorship Term shall be that of an independent contractor and not, for any purpose, that of an employee or agent with authority to bind the Company in any respect. All payments and other consideration made or provided to the Director under this Section 3 shall be made or provided without withholding or deduction of any kind, and the Director shall assume sole responsibility for discharging all tax or other obligations associated therewith.
  
 (d) Expense Reimbursements. During the Directorship Term, the Company shall reimburse the Director for (i) all reasonable out-of-pocket expenses incurred by the Director in attending any in-person meetings, provided that the Director complies with the generally applicable policies, practices and procedures of the Company for submission of expense reports, receipts or similar documentation of such expenses, and (ii) any costs associated with filings required to be made by the Director or any of the entities managed or controlled by Director to report beneficial ownership or the acquisition or disposition of securities of the Company. Any reimbursements for allocated expenses (as compared to out-of-pocket expenses of the Director) must be approved in advance by the Company. 
  
 4. Directorship Term. The “Directorship Term,” as used in this Agreement, shall mean the period commencing on the date hereof and terminating on the earlier of the date of the next annual stockholders meeting and the earliest of the following to occur:
  
 (a) the death of the Director;
  
 (b) the termination of the Director from his membership on the Board by the mutual agreement of the Company and the Director;
  
 (c) the removal of the Director from the Board by the majority stockholders of the Company; and
  
 (d) the resignation by the Director from the Board.
  
  	 
	2
	 
 
	 

  
 5. Director’s Representation and Acknowledgment. The Director represents to the Company that his execution and performance of this Agreement shall not be in violation of any agreement or obligation (whether or not written) that he may have with or to any person or entity, including without limitation, any prior or current employer. The Director hereby acknowledges and agrees that this Agreement (and any other agreement or obligation referred to herein) shall be an obligation solely of the Company, and the Director shall have no recourse whatsoever against any officer, director, employee, stockholder, representative or agent of the Company or any of their respective affiliates with regard to this Agreement.
  
 6. Director Covenants.
  
 (a) Unauthorized Disclosure. The Director agrees and understands that in the Director’s position with the Company, the Director has been and will be exposed to and receive information relating to the confidential affairs of the Company, including, but not limited to, technical information, business and marketing plans, strategies, customer information, other information concerning the Company’s products, services, promotions, development, financing, expansion plans, business policies and practices, and other forms of information considered by the Company to be confidential, and proprietary and in the nature of trade secrets. The Director agrees that during the Directorship Term and thereafter, the Director will keep such information confidential and will not disclose such information, either directly or indirectly, to any third person or entity without the prior written consent of the Company; provided, however, that (i) the Director shall have no such obligation to the extent such information is or becomes publicly known or generally known in the Company’s industry other than as a result of the Director’s breach of his obligations hereunder and (ii) the Director may, after giving prior notice to the Company to the extent practicable under the circumstances, disclose such information to the extent required by applicable laws or governmental regulations or judicial or regulatory process. This confidentiality covenant has no temporal, geographical or territorial restriction. Upon termination of the Directorship Term, the Director will promptly return to the Company and/or destroy at the Company’s direction all property, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs, machines, technical data, other product or document, and any summary or compilation of the foregoing, in whatever form, including, without limitation, in electronic form, which has been produced by, received by or otherwise submitted to the Director in the course or otherwise as a result of the Director’s position with the Company during or prior to the Directorship Term, provided that the Company shall retain such materials and make them available to the Director if requested by him in connection with any litigation against the Director under circumstances in which (i) the Director demonstrates to the reasonable satisfaction of the Company that the materials are necessary to his defense in the litigation and (ii) the confidentiality of the materials is preserved to the reasonable satisfaction of the Company.
  
 (b) Non-Solicitation. During the Directorship Term and for a period of three (3) years thereafter, the Director shall not interfere with the Company’s relationship with, or endeavor to entice away from the Company, any person who, on the date of the termination of the Directorship Term and/or at any time during the one year period prior to the termination of the Directorship Term, was an employee or customer (including those reasonably expected to be a customer) of the Company or otherwise had a material business relationship with the Company.
  
  	 
	3
	 
 
	 

  
 (c) Remedies. The Director agrees that any breach of the terms of this Section 6 would result in irreparable injury and damage to the Company for which the Company would have no adequate remedy at law. The Director therefore also agrees that in the event of said breach or any threat of breach, the Company shall be entitled to an immediate injunction and restraining order to prevent such breach and/or threatened breach and/or continued breach by the Director and/or any and all entities acting for and/or with the Director, without having to prove damages or paying a bond, in addition to any other remedies to which the Company may be entitled at law or in equity. The terms of this paragraph shall not prevent the Company from pursuing any other available remedies for any breach or threatened breach hereof, including, but not limited to, the recovery of damages from the Director. The Director acknowledges that the Company would not have entered into this Agreement had the Director not agreed to the provisions of this Section 6.
  
 (d) The provisions of this Section 6 shall survive any termination of the Directorship Term, and the existence of any claim or cause of action by the Director against the Company, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by the Company of the covenants and agreements of this Section 6.
  
 7. Indemnification. The Company agrees to indemnify the Director for his activities as a member of the Board as set forth in the Director and Officer Indemnification Agreement attached hereto as Exhibit A. 
  
 8. Non-Waiver of Rights. The failure to enforce at any time the provisions of this Agreement or to require at any time performance by the other party hereto of any of the provisions hereof shall in no way be construed to be a waiver of such provisions or to affect either the validity of this Agreement or any part hereof, or the right of either party hereto to enforce each and every provision in accordance with its terms. No waiver by either party hereto of any breach by the other party hereto of any provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions at that time or at any prior or subsequent time.
  
 9. Notices. Every notice relating to this Agreement shall be in writing and shall be given by personal delivery, overnight delivery or by registered or certified mail, postage prepaid, return receipt requested; to:
  
 If to the Company:
  
 BioCorRx Inc. 
 2390 East Orangewood Avenue, Suite 575
 Anaheim, CA 92806
 Attn: Lourdes Felix, Chief Financial Officer/Chief Operating Officer
 Telephone: (714) 462-4880
 Facsimile: (657) 210-4683
  
  	 
	4
	 
 
	 

  
 with a copy (which shall not constitute notice) to:
  
 Lucosky Brookman LLP
 101 Wood Avenue South
 Woodbridge, New Jersey 08830
 Attn: Joseph M. Lucosky, Esq.
 Telephone: (732) 395-4400
 Facsimile: (732) 395-4401 
  
 If to the Director:
  
 Kent Emry
 _____________________________
 _____________________________
 Telephone: 
  
 Either of the parties hereto may change their address for purposes of notice hereunder by giving notice in writing to such other party pursuant to this Section 9.
  
 10. Binding Effect/Assignment. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, executors, personal representatives, estates, successors (including, without limitation, by way of merger) and assigns, as applicable. Notwithstanding the provisions of the immediately preceding sentence, neither the Director nor the Company shall assign all or any portion of this Agreement without the prior written consent of the other party.
  
 11. Entire Agreement. This Agreement (together with the other agreements referred to herein) sets forth the entire understanding of the parties hereto with respect to the subject matter hereof and supersedes all prior agreements, written or oral, between them as to such subject matter.
  
 12. Severability. If any provision of this Agreement, or any application thereof to any circumstances, is invalid, in whole or in part, such provision or application shall to that extent be severable and shall not affect other provisions or applications of this Agreement.
  
  	 
	5
	 
 
	 

  
 13. Governing Law. This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Nevada, without regard to its conflict of laws rules. The parties hereto hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought in any court of the State of Nevada (the “Nevada Court”), and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive jurisdiction of the Nevada Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) waive any objection to the laying of venue of any such action or proceeding in the Nevada Court, and (v) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Nevada Court has been brought in an improper or inconvenient forum.
  
 14. Legal Fees. The parties hereto agree that the non-prevailing party in any dispute, claim, action or proceeding between the parties hereto arising out of or relating to the terms and conditions of this Agreement or any provision thereof (a “Dispute”), shall reimburse the prevailing party for reasonable attorney’s fees and expenses incurred by the prevailing party in connection with such Dispute; provided, however, that the Director shall only be required to reimburse the Company for its fees and expenses incurred in connection with a Dispute if the Director’s position in such Dispute was found by the court, arbitrator or other person or entity presiding over such Dispute to be frivolous or advanced not in good faith.
  
 15. Modifications. Neither this Agreement nor any provision hereof may be modified, altered, amended or waived except by an instrument in writing duly signed by the party to be charged.
  
 16. Tense and Headings. Whenever any words used herein are in the singular form, they shall be construed as though they were also used in the plural form in all cases where they would so apply. The headings contained herein are solely for the purposes of reference, are not part of this Agreement and shall not in any way affect the meaning or interpretation of this Agreement.
  
 17. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument.
  
 [-Signature Page Follows-]
  
  	 
	6
	 
 
	 

  
 IN WITNESS WHEREOF, the Company has caused this Director Agreement to be executed by authority of its Board of Directors, and the Directors has hereunto set his hand, on the day and year first above written.
  
  
 BIOCORRX INC.
  	  
	 	 	 	 	 
	 By:
		 	By:		 
	  
		 	 		 
	  
		 	 		 

  
  
 DIRECTOR 
  
 ______________________________ 
 ____________,    individual
  
  
  
 [Signature page to Director Agreement]
  
  	 
	7
	 
 
	 

  
 EXHIBIT A
  
 DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT
  
 See attached.
  
  
  
 [Exhibit A to Director Agreement]
  
  
  	 8COMPANY OFFICERS CERTIFICATE WITH FORM OF 4.40% SENIOR NOTES DUE 2029

 Exhibit 4.3 

OFFICERS’ CERTIFICATE 

PURSUANT TO SECTION 3.1 OF THE INDENTURE 

We, the undersigned Matthew C. Flanigan and Benjamin M. Burns, Executive Vice President and Chief Financial Officer and Vice President and
Treasurer, respectively, of Leggett & Platt, Incorporated (the “Company”), in accordance with Section 3.1 of the Senior Indenture, dated as of May 6, 2005 (the “Indenture”), of the
Company to U.S. Bank National Association, as successor trustee (the “Trustee”) (capitalized terms used herein and not defined herein have the meaning specified in the Indenture), and pursuant to the Resolutions adopted by
the Company’s Board of Directors as of November 6, 2018, have established a series of Debt Securities with the following terms and characteristics (the numbered clauses set forth below corresponding to the numbered subsections of
Section 3.1 of the Indenture): 
  

	 	(1)	 the title of the Debt Securities of the series shall be 4.400% Senior Notes due 2029 (the
“Notes”); 

  

	 	(2)	 the Notes may be issued in an aggregate principal amount not exceeding $500,000,000 except as provided in
Section 3.1(2) and the second to last paragraph of Section 3.1 of the Indenture. The Company may, without giving notice to or seeking the consent of the Holders of the Notes, issue additional securities having the same terms (except for
the issue date and, in some cases, the public offering price, the first Interest Payment Date and the initial Interest accrual date) as, and ranking equally and ratably with the Notes. Any additional securities having such similar terms, together
with the Notes, will constitute a single series of securities under the Indenture, including for purposes of voting and redemptions. Such additional securities will only be issued as part of the series of the Notes if they are fungible with the
Notes for U.S. federal income tax purposes. 

  

	 	(3)	 the Notes will be issued at a price to the public of 99.391% of their principal amount and net proceeds to the
Company from the sale of the Notes shall be 98.741% of the principal amount; the Notes shall be payable upon declaration of acceleration of the maturity at their principal amount, or upon redemption thereof at the redemption prices and upon the
terms set forth in the Form of Note attached hereto as Exhibit A; 

  

	 	(4)	 the Notes will be issued on March 7, 2019 and the due date for principal is March 15, 2029;

  

	 	(5)	 the Notes will bear interest at the rate of 4.400% per annum, computed on the basis of a 360-day year of twelve 30-day months and interest will begin to accrue from March 7, 2019; the Interest Payment Dates on which such interest shall be payable are every
March 15 and September 15, beginning September 15, 2019, and the Regular Record Date for the interest payable on any Interest Payment Date (other than at maturity or upon redemption) is March 1 for the March 15 Interest
Payment Date and September 1 for the September 15 Interest Payment Date (whether or not a Business Day); Interest payable at maturity or upon redemption shall be paid to the person to whom principal is paid; 

	 	(6)	 the corporate trust office of U.S. Bank National Association, Corporate Trust Services, SL-MO-T3CT, One U.S. Bank Plaza, St. Louis, MO 63101 shall be the place where the principal of (and premium, if any) and interest on the Notes shall be payable; the last
sentence of Section 12.1 of the Indenture shall not apply to the Notes; and any Global Note shall not require any notation to evidence payment of principal or interest; 

 

	 	(7)	 the Company is obligated, unless it has exercised its right to redeem the Notes in whole (as referenced in
paragraph (8) hereof) by giving notice of such redemption to the Holders of the Notes, to offer to repurchase the Notes at a price equal to 101% of the principal amount of the Notes, plus accrued and unpaid interest to, but excluding, the date
of repurchase upon a Change of Control Repurchase Event as defined within and upon the terms set forth in the Form of Note attached hereto as Exhibit A; 

  

	 	(8)	 the Notes may be redeemed by the Company at its option at the redemption prices and upon the terms set forth in
the Form of Note attached hereto as Exhibit A; 

  

	 	(9)	 the Notes shall be denominated in Dollars and issued in denominations of $2,000 or any amount in excess thereof
which is an integral multiple of $1,000; 

  

	 	(10)	 the Notes are not to be issued as Discount Securities; 

 

	 	(11)	 Articles IV and XV of the Indenture shall be applicable to the Notes. In addition, and in accordance with
Section 3.1(11) of the Indenture, the covenant referenced in paragraph (7) hereof, shall be subject to covenant defeasance at any time by the Company pursuant to the terms of Article XV of the Indenture, and any noncompliance with
such terms, provisions or covenants in paragraph (7) hereof shall not constitute a default or Event of Default with respect to the Indenture or the Notes upon compliance with the conditions set forth in said Article XV;

  

	 	(12)	 the Notes shall be issued only as Registered Securities; 

 

	 	(13)	 Section 3.1(13) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(14)	 the Notes shall be denominated in Dollars and payment of the principal of and interest on the Notes will be in
Dollars; 

  

	 	(15)	 Section 3.1(15) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(16)	 the Notes shall be dated March 7, 2019 or any such later date of authentication; 

 

	 	(17)	 Section 3.1(17) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

	 	(18)	 Section 3.1(18) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(19)	 Section 3.1(19) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(20)	 Section 3.1(20) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(21)	 Section 3.1(21) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(22)	 Section 3.1(22) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(23)	 Section 3.1(23) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(24)	 the Notes shall be issued in whole in the form of one or more Global Notes; the U.S. Depositary for the Global
Notes shall be The Depository Trust Company; and Section 3.4(c) of the Indenture shall be applicable to the Notes; 

  

	 	(25)	 U.S. Bank National Association, the Trustee under the Indenture, shall be the Paying Agent with respect to the
Notes; 

  

	 	(26)	 Section 3.1(26) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(27)	 Section 3.1(27) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(28)	 Section 3.1(28) of the Indenture is inapplicable to the Notes and reference thereto is intentionally
omitted; 

  

	 	(29)	 Section 7.4 of the Indenture shall be amended and replaced in its entirety with respect to the Notes by
the following: 

 SECTION 7.4. Reports by Company. 

The Company will: 
  

	 	(1)	 file with the Trustee, after the Company is required to file the same with the Commission, copies of the annual
reports and of the information, documents and other reports (or copies of such portions of any of the foregoing as the Commission may from time to time by rules and regulations prescribe) which the Company may be required to file with the Commission
pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended. 

	 	(2)	 file with the Trustee and the Commission, in accordance with rules and regulations prescribed from time to time
by the Commission, such additional information, documents and reports with respect to compliance by the Company with the conditions and covenants of this Indenture as may be required from time to time by such rules and regulations; and

  

	 	(3)	 transmit to all Holders of Debt Securities, in the manner and to the extent provided in Section 7.3,
within 30 days after the filing thereof with the Trustee, such summaries of any information, documents and reports required to be filed by the Company pursuant to paragraphs (1) and (2) of this Section as may be required by rules and
regulations prescribed from time to time by the Commission; 

  

	 	(30)	 Except as provided for in clause (7) above, Section 3.1(30) of the Indenture is inapplicable to the
Notes and reference thereto is intentionally omitted; 

  

	 	(31)	 The Holder of the Notes hereby waives, to the fullest extent permitted by applicable law, any right it may have
to a trial by jury in any legal proceeding, directly or indirectly, arising out of or relating to the Notes or the Indenture (whether based on contract, tort or any other theory). 

Any action or proceeding, judicial or otherwise, at law or in equity or in bankruptcy or otherwise, or for the appointment of a receiver,
trustee, liquidator, custodian, sequestrator (or similar official) or for any other remedy with respect to the Indenture and/or the Notes shall be subject to Section 5.7 of the Indenture. 

The Notes shall be substantially in the Form of Note attached hereto as Exhibit A, which Form of Note is hereby authorized and approved
and shall have such further terms as set forth in such Form of Note. 

 IN WITNESS WHEREOF, we have hereunto signed our names this 7th day of March, 2019 
  

	
	 /s/ Matthew C. Flanigan

	Matthew C. Flanigan
	Executive Vice President
	and Chief Financial Officer
	
	 /s/ Benjamin M. Burns

	Benjamin M. Burns
	Vice President and Treasurer

 Exhibit A – Form of Note 

 Unless this certificate is presented by an authorized representative of The Depository Trust
Company, a New York corporation (“DTC” or the “U.S. Depositary”), to the Company (as defined below) or its agent for registration of transfer, exchange or payment, and any certificate issued is registered in the name of
Cede & Co. or in such other name as is requested by an authorized representative of the U.S. Depositary (and any payment is made payable to Cede & Co. or to such other entity as is requested by an authorized representative of the
U.S. Depositary), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner hereof, Cede & Co., has an interest herein. 

This Debt Security may not be transferred except as a whole by the U.S. Depositary to a nominee of the U.S. Depositary or by a nominee of the
U.S. Depositary to the U.S. Depositary or another nominee of the U.S. Depositary or by the U.S. Depositary or any such nominee to a successor U.S. Depositary or a nominee of such successor U.S. Depositary, unless and until this Debt Security is
exchanged in whole or in part for Debt Securities in definitive form. 

 LEGGETT & PLATT, INCORPORATED 

4.400% Senior Note due 2029 
  

 
  

					
	REGISTERED	  		  	REGISTERED
			
	No. R-l	  		  	CUSIP NO. 524660AZ0
			
		  		  	$500,000,000

 LEGGETT & PLATT, INCORPORATED, a corporation duly organized and existing under the laws of Missouri
(herein called the “Company”, which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE & CO., or registered assigns, the principal sum of FIVE
HUNDRED MILLION DOLLARS on March 15, 2029 and to pay interest thereon from March 7, 2019 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semiannually in arrears on March 15 and
September 15 in each year, commencing September 15, 2019, and at Stated Maturity or redemption, if any, at the rate of 4.400% per annum until the principal hereof is paid or made available for payment. 

Interest so payable shall be computed on the basis of a 360-day year consisting of twelve 30-day months. The interest so payable, and paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor
Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be the March 1 or September 1 (whether or not a Business Day), as the case may be, immediately preceding such Interest Payment
Date. Notwithstanding the foregoing, interest payable at Maturity shall be paid to the Person to whom principal shall be paid. Except as otherwise provided in the Indenture, any such interest not punctually paid or duly provided for will forthwith
cease to be payable to the Holder on such Regular Record Date and such Defaulted Interest may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record
Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful
manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

Payment of the principal of (and premium, if any) and interest on this Security will be made at the offices of U.S. Bank National Association,
Corporate Trust Services, SL-MO-T3CT, One U.S. Bank Plaza, St. Louis, MO 63101, or at such other office or agency as may be designated for such purpose by the Company
from time to time and will be made in such coin or currency of the United States of America as at the time of payment is legal tender for the payment of public and private debts; provided, however, that at the option of the Company payment of
interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register, or in the case of Holders of $1,000,000 or more in aggregate principal amount of the Securities of this series,
the Person entitled thereto shall be entitled to receive payment of interest by wire transfer to an account of such Person 

 
located in the United States, provided, that such Person shall have given to the Paying Agent satisfactory wire transfer instructions by the Regular Record Date preceding the applicable Interest
Payment Date, with reference to the identifying information concerning such Holder to be found in the Security Register. 
 The Securities
of this series are subject to redemption prior to Stated Maturity as described on the reverse hereof. 
 Reference is hereby made to the
further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place. 

Unless the certificate of authentication hereon has been executed by or on behalf of the Trustee referred to on the reverse hereof by manual
signature, this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

Dated: March 7, 2019 
  

			
	LEGGETT & PLATT, INCORPORATED
		
	By:	 	 /s/ Matthew C. Flanigan

		 	Name: Matthew C. Flanigan
		 	Title:   Executive Vice President
		 	            and Chief Financial Officer
		
	By:	 	 /s/ Benjamin M. Burns

		 	Name: Benjamin M. Burns
		 	Title:   Vice President and Treasurer

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated therein referred to in the within-mentioned
Indenture. 
  

			
	U.S. Bank National Association, as Trustee
		
	By:	 	 /s/ Cheryl A. Rain

		 	                Authorized Officer

 Dated: March 7, 2019 

 REVERSE SIDE OF NOTE 

4.400% Senior Note due 2029 

Section 1. Indenture 

This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to be
issued in one or more series under a Senior Indenture, dated as of May 6, 2005 (herein called the “Indenture”), between the Company and U.S. Bank National Association, as successor Trustee (herein called the “Trustee,” which
term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the
Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be authenticated and delivered. The acceptance of this Security shall be deemed to constitute the consent and agreement by the Holders
hereof to all of the terms and provisions of the Indenture. This Security is one of the series designated on the face hereof. By the terms of the Indenture, additional Securities of other separate series, which may vary as to date, amount, Stated
Maturity, interest rate or method of calculating the interest rate and in other respects as therein provided, may be issued in an unlimited principal amount. 

The Company may, without giving notice to or seeking the consent of the Holders of this Security, issue additional securities having the same
terms (except for the issue date and, in some cases, the public offering price, the first Interest Payment Date and the initial Interest accrual date) as, and ranking equally and ratably with this Security. Any additional securities having such
similar terms, together with this Security, will constitute a single series of securities under the Indenture, including for purposes of voting and redemptions. Such additional securities will only be issued as part of the series of this Security if
they are fungible with this Security for U.S. federal income tax purposes. 
 If any Interest Payment Date, Redemption Date or the Stated
Maturity of this Security shall not be a Business Day at any Place of Payment, then (notwithstanding any other provision of the Indenture or this Security), payment of interest or principal due on this Security need not be made at such Place of
Payment on such date, but may be made on the immediately succeeding Business Day at the Place of Payment, with the same force and effect as if made on the Interest Payment Date, Redemption Date or at Stated Maturity, provided that no interest shall
accrue on such unpaid interest or principal for the period from and after such Interest Payment Date, Redemption Date or Stated Maturity, as the case may be, to such Business Day. 

Section 2. Optional Redemption 

Except as set forth below, this Security is not redeemable prior to Stated Maturity and is not entitled to the benefit of a sinking fund or any
analogous provision. 
 On or after December 15, 2028 (three months prior to the Stated Maturity of this Security (the “Par Call
Date”)), the Securities of this series are redeemable, in whole or in part, at the option of the Company, at any time and from time to time, at a Redemption Price equal to 100% of the principal amount of the Securities of this series to be
redeemed plus accrued and unpaid interest thereon to, but excluding, the Redemption Date. 

 Prior to the Par Call Date, the Securities of this series are redeemable, in whole or in
part, at the option of the Company, at any time and from time to time, at a Redemption Price equal to the greater of (i) 100% of the principal amount of the Securities of this series to be redeemed, and (ii) as determined by the Quotation Agent
(as defined below), the sum of the present values of the remaining scheduled payments of principal and interest thereon that would be due if the Securities of this series to be redeemed matured on the Par Call Date (not including any portion of
those payments of interest accrued as of the date of redemption) discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve
30-day months) at the Adjusted Treasury Rate (as defined below) plus 30 basis points, plus, in each case, accrued and unpaid interest thereon to, but excluding, the Redemption Date. 

“Adjusted Treasury Rate” means, with respect to any Redemption Date, the rate per annum equal to the semi-annual equivalent yield to
maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for that Redemption Date. 

“Comparable Treasury Issue” means the United States Treasury security selected by the Quotation Agent as having a maturity
comparable to the remaining term of the Securities of this series to be redeemed (assuming for this purpose that the Securities of this series to be redeemed matured on the Par Call Date) that would be utilized, at the time of selection and in
accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of those Securities of this series. 

“Comparable Treasury Price” means, with respect to any Redemption Date, (i) the average of the Reference Treasury Dealer
Quotations for the Redemption Date, after excluding the highest and lowest Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent obtains fewer than five Reference Treasury Dealer Quotations, the average of all such Reference
Treasury Dealer Quotations. 
 “Quotation Agent” means the Reference Treasury Dealer appointed by the Company. 

“Reference Treasury Dealer” means each of (i) J.P. Morgan Securities LLC and Wells Fargo Securities, LLC and their respective
successors, and three additional primary U.S. Government securities dealers in New York, New York (each a “Primary Treasury Dealer”) selected by the Company and their successors; provided, however, that if any of them shall cease to be a
Primary Treasury Dealer, the Company shall substitute another Primary Treasury Dealer; and (ii) any other Primary Treasury Dealers selected by the Company. 

“Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any Redemption Date, the average,
as determined by the Quotation Agent, after consultation with the Company, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Quotation Agent by
that Reference Treasury Dealer at 5:00 p.m., New York City time, on the third Business Day preceding that Redemption Date. 

 In case of any redemption occurring prior to the Par Call Date, the Company shall give the
Trustee notice of the related redemption price promptly after the calculation thereof and the Trustee shall not be responsible for such calculation. 

Notice of any redemption shall be delivered not less than 30 days but not more than 60 days before the Redemption Date to the Holders of the
Securities of this series to be redeemed, at each Holder’s address appearing in the Security Register, but failure to give such notice in the manner herein provided to the Holder of any Securities of this series designated for redemption shall
not affect the validity of the proceedings for the redemption of any other such Security or portion thereof. Any notice that is delivered to the Holders in the manner herein provided shall be conclusively presumed to have been duly given, whether or
not the Holder receives the notice. Notice of redemption having been given as aforesaid, the Securities of this series so to be redeemed shall, on the Redemption Date, become due and payable at the Redemption Price. Unless the Company defaults in
payment of the Redemption Price, on and after the Redemption Date, interest will cease to accrue on the Securities of this series or portions thereof called for redemption. If less than all of the Securities of this series are to be redeemed, the
Securities of this series to be redeemed shall be selected by the Trustee by such method as the Trustee shall deem fair and appropriate; provided, that as long as the Securities of this series are represented by one or more Global Notes, beneficial
interests in the Securities of this series will be selected for redemption by the U.S. Depositary in accordance with its standard procedures therefor. 

In the event of a redemption of this Security in part only, a new Security or Securities of this series, of like tenor of any authorized
denomination for the unredeemed portion hereof will be issued in the name of the Holder of this Security upon cancellation hereof. Except as otherwise provided herein, Article XIII of the Indenture shall apply to this Security. 

Section 3. Repurchase Upon a Change of Control Repurchase Event 

If a Change of Control Repurchase Event (as defined below) occurs, unless the Company has exercised its right to redeem the Securities of this
series in whole as described in Section 2 by giving notice of such redemption to each Holder of the Securities of this series, the Company will make an offer to each Holder of the Securities of this series to repurchase all or any part (equal
to $1,000 and integral multiples of $1,000 in excess thereof, provided, that the unrepurchased portion of any Security of this series must be in a minimum principal amount of $2,000) of that Holder’s Securities at a repurchase price in cash
equal to 101% of the aggregate principal amount of the Securities of this series repurchased plus any accrued and unpaid interest on the Securities of this series repurchased to, but excluding, the date of repurchase. Within 30 days following any
Change of Control Repurchase Event or, at the Company’s option, prior to any Change of Control (as defined below), but after the public announcement of an impending Change of Control, the Company will send, or shall cause to be sent, a notice
to each Holder of the Securities of this series, with a copy to the Trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to repurchase Securities of this series on
the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is sent (the “Change of Control Payment Date”). The notice shall, if sent prior to the date of
consummation of the Change of Control, state that the offer to repurchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice. 

 The Company will comply with the requirements of Rule
14e-l under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in
connection with the repurchase of the Securities of this series as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with this Section 3, the Company will comply
with the applicable securities laws and regulations and will not be deemed to have breached its obligations under this Section 3 by virtue of such conflict. 

On the Change of Control Payment Date, the Company will, to the extent lawful: 

 

	 	(a)	 accept for payment all Securities of this series or portions of Securities of this series properly tendered
pursuant to the Company’s offer; 

  

	 	(b)	 deposit with the Paying Agent an amount equal to the aggregate purchase price in respect of all Securities of
this series or portions of Securities of this series properly tendered; and 

  

	 	(c)	 deliver or cause to be delivered to the Trustee the Securities of this series properly accepted, together with
an Officers’ Certificate stating the aggregate principal amount of Securities of this series being purchased by the Company. 

The Company will not be required to make an offer to repurchase the Securities of this series upon a Change of Control Repurchase Event if a
third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements in this Section 3 for an offer made by the Company and such third party purchases all Securities of this series properly tendered and
not withdrawn under its offer. An offer to repurchase the Securities of this series upon a Change of Control Repurchase Event may be made in advance of a Change of Control Repurchase Event, if a definitive agreement is in place for a Change of
Control at the time of the making of such an offer. 
 “Below Investment Grade Rating Event” occurs if the rating on the
Securities of this series is lowered by each of the Rating Agencies (as defined below) and the Securities of this series cease to be rated Investment Grade by each Rating Agency on any date during the period (the “Trigger Period”)
commencing on the date of first public announcement by the Company of any Change of Control (or pending Change of Control) and ending 60 days following consummation of such Change of Control (which Trigger Period will be extended following
consummation of a Change of Control for so long as any of the Rating Agencies has publicly announced that it is considering a possible ratings downgrade). If a Rating Agency is not providing a rating for the Securities of this series at the
commencement of any Trigger Period, the ratings on the Securities of this series will be deemed to have been lowered below Investment Grade by such Rating Agency during that Trigger Period. Notwithstanding the foregoing, no Below Investment Grade
Rating Event will be deemed to have occurred in connection with any particular Change of Control unless and until such Change of Control has actually been consummated. 

“Change of Control” means the occurrence of any of the following: 

 (1) the direct or indirect sale, transfer, conveyance or other disposition (other than by
way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the Company’s properties or assets and those of its Subsidiaries taken as a whole to any “person” (as that term is used in
Section 13(d)(3) of the Exchange Act), other than the Company or one of its Subsidiaries; 
 (2) the adoption of a plan relating to the
Company’s liquidation or dissolution; 
 (3) the first day on which a majority of the members of the Company’s Board of Directors
are not Continuing Directors; 
 (4) the consummation of any transaction or series of related transactions (including, without limitation,
any merger or consolidation) the result of which is that any “person” (as that term is used in Section 13(d)(3) of the Exchange Act), other than the Company or one of its Subsidiaries, becomes the beneficial owner, directly or
indirectly, of more than 50% of the then outstanding shares of the Company’s Voting Stock, measured by voting power rather than number of shares; or 

(5) the Company consolidates with, or merges with or into, any person, or any person consolidates with, or merges with or into the Company, in
any such event pursuant to a transaction in which any of the Company’s outstanding Voting Stock or Voting Stock of such other person is converted into or exchanged for cash, securities or other property, other than any such transaction where
the Company’s Voting Stock outstanding immediately prior to such transaction constitutes, or is converted into or exchanged for, Voting Stock representing more than 50% of the voting power of the Voting Stock of the surviving person immediately
after giving effect to such transaction. 
 Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (i) the
Company becomes a direct or indirect wholly-owned subsidiary of a holding company and (ii) (A) the direct or indirect holders of the Voting Stock of such holding company immediately following that transaction are substantially the same as the
holders of the Company’s Voting Stock immediately prior to that transaction or (B) immediately following that transaction no person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner,
directly or indirectly, of more than 50% of the Voting Stock of such holding company. 
 “Change of Control Repurchase
Event” means the occurrence of both a Change of Control and a Below Investment Grade Rating Event. 
 “Continuing
Directors” means, as of any date of determination, any member of the Company’s Board of Directors who (1) was a member of such Board of Directors on the date of the issuance of the Securities of this series; or (2) was
nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a
specific vote or by approval of the Company’s proxy statement in which such member was named as a nominee for election as a director). 

 Without limiting the generality of the foregoing, “Continuing Director” shall include one or more
directors or nominees who are part of a dissident slate of directors in connection with a proxy contest, which director or nominee is approved by the Company’s Board of Directors as a Continuing Director for the purposes hereof or otherwise,
even if such Board of Directors does not approve or opposed or opposes the directors for purposes of such proxy contest. As a result, Holders of the Securities of this series would not be entitled to require the Company to purchase such Securities
under such circumstances. 
 “Investment Grade” means a rating of Baa3 or better by Moody’s (or its equivalent under
any successor rating categories of Moody’s) and a rating of BBB- or better by S&P (or its equivalent under any successor rating categories of S&P) or the equivalent investment grade credit rating
from any additional Rating Agency or Rating Agencies selected by the Company, in accordance with the definition of “Rating Agency” below. 

“Moody’s” means Moody’s Investors Service Inc., and its successors. 

“Rating Agency” means (1) each of Moody’s and S&P; and (2) if any of Moody’s or S&P ceases to
rate the Securities of this series or fails to make a rating of the Securities of this series publicly available for reasons outside of the Company’s control, a “nationally recognized statistical rating organization” within the
meaning of Section 3(a)(62) of the Exchange Act, selected by the Company as a replacement agency for Moody’s or S&P, as the case may be. 

“S&P” means S&P Global Ratings, a division of S&P Global Inc., and its successors. 

“Voting Stock” means, with respect to any person, capital stock of any class or kind the holders of which are ordinarily, in
the absence of contingencies, entitled to vote for the election of directors (or persons performing similar functions) of such person, even if the right so to vote has been suspended by the happening of such a contingency. 

Section 4. Events of Default 

If an Event of Default with respect to the Securities of this series shall occur and be continuing, the principal of the Securities of this
series may (subject to the conditions set forth in the Indenture) be declared due and payable in the manner and with the effect provided in the Indenture. 

Section 5. Discharge and Defeasance 

The Indenture contains provisions for defeasance at any time of the Company’s obligations in respect of (i) the entire indebtedness
of this Security or (ii) certain restrictive covenants with respect to this Security, including the covenant contained in Section 3 hereof, in each case upon compliance with certain conditions set forth therein. 

Section 6. Supplemental Indentures 

The Indenture permits, with certain exceptions as therein provided, the Company to enter into a supplemental indenture with the Trustee to
amend certain provisions thereof and modify the rights and obligations of the Company and the rights of the Holders of the Securities of each 

 
series to be affected under the Indenture at any time with the consent of the Holders of not less than a majority in aggregate principal amount of the Securities at the time Outstanding of each
series to be affected and, for certain purposes, without the consent of the Holders of any Securities at the time Outstanding. The Indenture also contains provisions permitting the Holders of specified percentages in aggregate principal amount of
the Securities of each series at the time Outstanding, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their
consequences. Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange
hereof or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security. 
 No reference herein to the
Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and interest on this Security at the times, place and rate, and in the
coin or currency, herein prescribed. 
 Section 7. Denominations; Transfer; Exchange 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Security
Register, upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of
transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or such Holder’s attorney duly authorized in writing, and thereupon one or more new Securities of this series, of like tenor and of
authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 
 The
Securities of this series are issuable only in registered form without coupons in denominations of $2,000 and any amount in excess thereof which is an integral multiple of $1,000. As provided in the Indenture and subject to certain limitations
therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering the same. 

No service charge shall be made for any such registration of transfer or exchange, except as provided in the Indenture, but the Company may
require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 Section 8.
Persons Deemed Owners 
 The Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this
Security is registered in the Security Register as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 

 Section 9. Governing Law 

This Security shall be governed by and construed in accordance with the laws of the State of New York, without regard for principles of
conflicts of law (other than Section 5-1401 of the General Obligations Law of the State of New York). 

Section 10. Defined Terms 

All terms used in this Security which are defined in the Indenture shall have the meanings assigned to them in the Indenture. 

Section 11. No Recourse Against Others 

As provided in the Indenture, no recourse shall be had for the payment of the principal of or interest on any Securities, or any part thereof,
or for any claim based thereon or otherwise in respect thereof, or of the indebtedness represented thereby, or upon any obligation, covenant or agreement under this Security or the Indenture, against, and no personal liability whatsoever shall
attach to, or be incurred by, any incorporator, stockholder, officer or director, as such, past, present or future of the Company or of any predecessor or successor corporation (either directly or through the Company or a predecessor or successor
corporation), whether by virtue of any constitutional provision, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly agreed and understood that the Indenture and all the Securities are solely
corporate obligations and that any such personal liability is hereby expressly waived and released as a condition of, and as a part of the consideration for, the execution of the Indenture and the issuance of the Securities. 

Section 12. Waiver Jury Trial 

THE HOLDER OF THIS SECURITY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY
LEGAL PROCEEDING, DIRECTLY OR INDIRECTLY, ARISING OUT OF OR RELATING TO THIS SECURITY OR THE INDENTURE (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). 

Section 13. Limitations on Suits 

Any action or proceeding, judicial or otherwise, at law or in equity or in bankruptcy or otherwise, or for the appointment of a receiver,
trustee, liquidator, custodian, sequestrator (or similar official) or for any other remedy with respect to the Indenture and/or this Security shall be subject to Section 5.7 of the Indenture. 

 FOR VALUE RECEIVED the undersigned hereby sells, assigns and transfers unto 

 
  

[Please insert social security or other identifying number of assignee] 

 
  

[Please print or typewrite name and address of assignee] 
  

 
 the within Security of LEGGETT & PLATT,
INCORPORATED and does hereby irrevocably constitute and appoint                             , Attorney, to
transfer said Security on the books of the within-mentioned Company, with full power of substitution in the premises. 

Dated:                         
        
  

	
	  

	Notice: The signature to this assignment must correspond with the name as written upon the face of the Security in every particular without alteration or enlargement or any change whatsoever.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}]]